Showing 1 to 2 of 2 results


ChemoID Test Significantly Improves Outcomes for Platinum-Resistant Ovarian Cancer
A phase 3 clinical trial published in Nature Partner Journal "Precision Oncology" demonstrates that the ChemoID test, analyzing tumor stem cells to guide chemotherapy selection, significantly improves response rates (50% vs 5%) and progression-free survival (11 months vs 3 months) in patients with p...
ChemoID Test Significantly Improves Outcomes for Platinum-Resistant Ovarian Cancer
A phase 3 clinical trial published in Nature Partner Journal "Precision Oncology" demonstrates that the ChemoID test, analyzing tumor stem cells to guide chemotherapy selection, significantly improves response rates (50% vs 5%) and progression-free survival (11 months vs 3 months) in patients with p...
Progress
48% Bias Score

Genetic Test for Stillborn Child Leads to Early Stomach Cancer Diagnosis
Content creator Sidney Raskind's genetic test, initially for his stillborn child's birth defect, unexpectedly revealed he has a rare, hereditary stomach cancer; he will undergo surgery in July and advocates for genetic testing.

Genetic Test for Stillborn Child Leads to Early Stomach Cancer Diagnosis
Content creator Sidney Raskind's genetic test, initially for his stillborn child's birth defect, unexpectedly revealed he has a rare, hereditary stomach cancer; he will undergo surgery in July and advocates for genetic testing.
Progress
32% Bias Score
Showing 1 to 2 of 2 results